Rituximab for the treatment of relapses in antineutrophil cytoplasmic antibody-associated vasculitis Academic Article uri icon

Overview

MeSH Major

  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents
  • Secondary Prevention

abstract

  • Re-treatment of AAV relapses with RTX and glucocorticoids appears to be a safe and effective strategy, regardless of previous treatment.

publication date

  • January 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4229846

Digital Object Identifier (DOI)

  • 10.1002/art.38788

PubMed ID

  • 25047592

Additional Document Info

start page

  • 3151

end page

  • 9

volume

  • 66

number

  • 11